Font Size: a A A
Keyword [Vaccinia virus]
Result: 61 - 80 | Page: 4 of 5
61. Experimental Research Of Recombinant Vaccinia Virus RVV-CCL5-SSTR2-Luc+in Targeted Cancer Treatment In Vitro
62. Construction Of H5N1 Avian Influenza Virus-like Particles Based On Vaccinia Virus Tiantan And Immunogenicity Analysis
63. Experimental Therapy To Colorectal Cancer Mouse Model With IL-7 Modified Vaccinia Virus
64. Recombinant Oncolytic Vaccinia Virus Expressing The Extracellular Domain Of CD155 For Cancer Therapy
65. Functional analysis of the vaccinia virus entry protein L1
66. Vaccinia virus E3L protein inhibits type I IFN induction through the RLH pathway and associates with MDA-5 and IKK-epsilon
67. Expression and structural investigations of the vaccinia virus protein VP11
68. Expression of cellular anti-viral antagonists from vaccinia virus to study the innate immune response and Z -DNA
69. Vaccinia virus regulation of the cellular immune response
70. Applicability of vaccinia virus as cloning and expression vector for bacterial genes: Mice immune responses to vaccinia virus expressing Brucella abortus and Listeria monocytogenes antigens
71. The inhibition of apoptosis and Bax activation by mitochondrial anti-apoptotic proteins encoded by vaccinia virus and ectromelia virus
72. Regulation of vaccinia virus post-replicative gene expression
73. Development and characterization of murine monoclonal antibodies capable of neutralizing vaccinia virus
74. Non-invasive molecular imaging of an EGFP and DRD2-expressing vaccinia virus
75. Determination of Oligomeric State and Role of the Acidic C Terminal Tail of Vaccinia Virus I3 Single Stranded DNA Binding Protein
76. Vaccinia virus I7L core protein proteinase
77. Vaccinia virus morphogenesis: Analyses of the A14, A30, and G7 proteins and investigations into the origin of the viral membrane
78. Role of the Vaccinia Virus E3 protein and its poxvirus orthologues in suppressing innate immune responses activated by RNA-based pathogen-associated molecular patterns
79. Investigation of vaccinia virus complement control protein as a potential therapeutic agent following traumatic spinal cord injury
80. Vaccinia virus complement control protein ameliorates collagen induced arthritis: Potential implications for therapy of rheumatoid arthritis
  <<First  <Prev  Next>  Last>>  Jump to